EPO and chronic kidney disease: The ongoing ERECT trial, placebo-controlled and double-blind, is currently investigating subcutaneous administration of EPO in men undergoing radical nerve-sparing prostatectomy [204], and positive results may have implications for the treatment of neurogenic ED in the course of CKD.